Kopecek J - Search Results

1

Bone-targeting macromolecular therapeutics.

Wang D, Miller SC, Kopecková P, Kopecek J. Wang D, et al. Among authors: kopecek j. Adv Drug Deliv Rev. 2005 May 25;57(7):1049-76. doi: 10.1016/j.addr.2004.12.011. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876403 Review.

2

Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors.

Wang D, Pechar M, Li W, Kopecková P, Brömme D, Kopecek J. Wang D, et al. Among authors: kopecek j. Biochemistry. 2002 Jul 16;41(28):8849-59. doi: 10.1021/bi0257080. Biochemistry. 2002. PMID: 12102627

3

Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems.

Wang D, Miller S, Sima M, Kopecková P, Kopecek J. Wang D, et al. Among authors: kopecek j. Bioconjug Chem. 2003 Sep-Oct;14(5):853-9. doi: 10.1021/bc034090j. Bioconjug Chem. 2003. PMID: 13129387

4

Targeted drug delivery for musculoskeletal diseases.

Wang D, Miller SC, Kopecek J. Wang D, et al. Among authors: kopecek j. Adv Drug Deliv Rev. 2005 May 25;57(7):935-7. doi: 10.1016/j.addr.2004.12.012. Epub 2005 Apr 19. Adv Drug Deliv Rev. 2005. PMID: 15876395 No abstract available.

5

Biopolymer-based delivery systems for advanced imaging and skeletal tissue-specific therapeutics.

Miller SC, Wang D, Kopecková P, Kopecek J. Miller SC, et al. Among authors: kopecek j. J Bone Miner Metab. 2005;23 Suppl:103-8. doi: 10.1007/BF03026333. J Bone Miner Metab. 2005. PMID: 15984424

6

Water-soluble HPMA copolymer--prostaglandin E1 conjugates containing a cathepsin K sensitive spacer.

Pan H, Kopecková P, Wang D, Yang J, Miller S, Kopecek J. Pan H, et al. Among authors: kopecek j. J Drug Target. 2006 Jul;14(6):425-35. doi: 10.1080/10611860600834219. J Drug Target. 2006. PMID: 17092842

7

Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.

Wang D, Sima M, Mosley RL, Davda JP, Tietze N, Miller SC, Gwilt PR, Kopecková P, Kopecek J. Wang D, et al. Among authors: kopecek j. Mol Pharm. 2006 Nov-Dec;3(6):717-25. doi: 10.1021/mp0600539. Mol Pharm. 2006. PMID: 17140259 Free PMC article.

8

Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer-alendronate conjugates.

Pan H, Sima M, Kopecková P, Wu K, Gao S, Liu J, Wang D, Miller SC, Kopecek J. Pan H, et al. Among authors: kopecek j. Mol Pharm. 2008 Jul-Aug;5(4):548-58. doi: 10.1021/mp800003u. Epub 2008 May 28. Mol Pharm. 2008. PMID: 18505266 Free PMC article.

9

HPMA copolymers: origins, early developments, present, and future.

Kopecek J, Kopecková P. Kopecek J, et al. Adv Drug Deliv Rev. 2010 Feb 17;62(2):122-49. doi: 10.1016/j.addr.2009.10.004. Epub 2009 Nov 14. Adv Drug Deliv Rev. 2010. PMID: 19919846 Free PMC article.

10

Cathepsin K inhibitor-polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis.

Wang D, Li W, Pechar M, Kopecková P, Brömme D, Kopecek J. Wang D, et al. Among authors: kopecek j. Int J Pharm. 2004 Jun 11;277(1-2):73-9. doi: 10.1016/j.ijpharm.2003.03.003. Int J Pharm. 2004. PMID: 15158970 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page